jm034108b_si_001.pdf (68.81 kB)

Thienyl and Phenyl α-Halomethyl Ketones:  New Inhibitors of Glycogen Synthase Kinase (GSK-3β) from a Library of Compound Searching

Download (68.81 kB)
journal contribution
posted on 20.09.2003, 00:00 by Santiago Conde, Daniel I. Pérez, Ana Martínez, Concepción Perez, Francisco J. Moreno
Glycogen synthase kinase (GSK-3β) plays a crucial role in Alzheimer's disease (AD). Its inhibition is a valid approach to the treatment of AD. In this initial letter, some thienyl and phenyl α-halomethyl ketones are described as new non-ATP competitive inhibitors of GSK-3β. They are considered as lead compounds for designing and synthesizing new series, to carry out SAR studies, clear up the mechanism of action, and, in general, evaluate their therapheutical usefulness.

History

Exports